PD-1/PD-L1 interaction up-regulates MDR1/P-gp expression in breast cancer cells via PI3K/AKT and MAPK/ERK pathways-Reference-Cited by-同舟云学术

PD-1/PD-L1 interaction up-regulates MDR1/P-gp expression in breast cancer cells via PI3K/AKT and MAPK/ERK pathways

Published:2017-10-20 Issue:59 Volume:8 Page:99901-99912
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Liu Shengwei¹,Chen Shuang¹,Yuan Weiguang²,Wang Hongyan³,Chen Kewang¹,Li Dianjun¹,Li Dalin⁴

Affiliation:

1. Department of Immunology, Harbin Medical University and Heilongjiang Provincial Key Laboratory for Infection and Immunity, Harbin Medical University and Heilongjiang Academy of Medical Science, 150081, Harbin, China

2. Department of Cancer Immunology, Cancer Institute of Harbin Medical University, Department of Cancer Immunology, Heilongjiang Academy of Medical Sciences, 150081, Harbin, China

3. Institute of Harbin Hematology and Oncology, Harbin First Hospital, 150010, Harbin, China

4. Department of Breast Surgery, Harbin Medical University Cancer Hospital, 150081, Harbin, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel insights into the regulation of exosomal PD-L1 in cancer: From generation to clinical application;European Journal of Pharmacology;2024-09

2. The clinicopathological significance and prognostic value of PD‐L1 in oral squamous cell carcinoma;Oral Diseases;2024-08-02

3. Harnessing the capacity of phytochemicals to enhance immune checkpoint inhibitor therapy of cancers: A focus on brain malignancies;Cancer Letters;2024-07

4. Factors correlating the expression of PD-L1;BMC Cancer;2024-05-25

5. PD-1/PD-L1 pathway: Current research in breast cancer;Breast Disease;2024-04-29